Bill Title: Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.

Spectrum: Partisan Bill (Democrat 2-0)

Status: (Engrossed) 2024-01-30 - referred to consumer affairs and protection [S03518 Detail]

---

Bill Drafts

Revision	Date	Format	Source	View
Introduced	2023-01-31	HTML/Text	Link	View

Amendments

Amendment	Date	Disposition	Format	Source	View
No bill amendments currently on file for New York S03518

Supplemental Documents

Title	Description	Date	Format	Source	View
No supplemental documents for New York S03518 currently on file.

Social Comments on NY S03518